Larson Financial Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395 Hold
36
﹤0.01% 3528
2026
Q1
$293 Sell
36
-700
-95% -$6.01K ﹤0.01% 3406
2025
Q4
$7.65K Buy
736
+662
+895% +$6.95K ﹤0.01% 2265
2025
Q3
$655 Buy
74
+36
+95% +$257 ﹤0.01% 3031
2025
Q2
$219 Buy
38
+4
+12% +$25 ﹤0.01% 3048
2025
Q1
$224 Buy
+34
New +$265 ﹤0.01% 2769

Other funds holding KURA

Larson Financial Group's KURA Position: Q2 2026 in Review

Larson Financial Group held its Kura Oncology (KURA) position steady in Q2 2026 at 36 shares worth $395. The position accounts for ﹤0.01% of the portfolio, ranked #3528.

Larson Financial Group first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.65K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Larson Financial Group held 36 shares of Kura Oncology worth $395 as of Q2 2026.
  • Larson Financial Group left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3528 holding.
  • Larson Financial Group first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Kura Oncology position peaked at $7.65K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.